These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23898156)

  • 1. Blinding in pharmacological trials: the devil is in the details.
    Wan M; Orlu-Gul M; Legay H; Tuleu C
    Arch Dis Child; 2013 Sep; 98(9):656-9. PubMed ID: 23898156
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?
    Webster RK; Bishop F; Collins GS; Evers AWM; Hoffmann T; Knottnerus JA; Lamb SE; Macdonald H; Madigan C; Napadow V; Price A; Rees JL; Howick J
    J Clin Epidemiol; 2021 Jul; 135():176-181. PubMed ID: 33662512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 4. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 6. Verapamil in mania.
    Warner JP
    Am J Psychiatry; 1993 Mar; 150(3):529-30. PubMed ID: 8434684
    [No Abstract]   [Full Text] [Related]  

  • 7. Ten Practical Recommendations for Improving Blinding Integrity and Reporting in Psychotherapy Trials.
    Mataix-Cols D; Andersson E
    JAMA Psychiatry; 2021 Sep; 78(9):943-944. PubMed ID: 34160570
    [No Abstract]   [Full Text] [Related]  

  • 8. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
    Bystritsky A; Waikar SV
    J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design of controlled experiments in the evaluation of non-therapeutic interventions.
    Buck C; Donner A
    J Chronic Dis; 1982; 35(7):531-8. PubMed ID: 7085845
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials of acupuncture: consensus recommendations for optimal treatment, sham controls and blinding.
    White AR; Filshie J; Cummings TM;
    Complement Ther Med; 2001 Dec; 9(4):237-45. PubMed ID: 12184353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features.
    Dal-Ré R; de Boer A; James SK
    J Clin Epidemiol; 2020 Oct; 126():193-201. PubMed ID: 32325221
    [No Abstract]   [Full Text] [Related]  

  • 12. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quality assessment of therapeutic clinical trials].
    Selbmann HK; Meisner C
    Internist (Berl); 2000 Apr; 41(4):344-8. PubMed ID: 10798182
    [No Abstract]   [Full Text] [Related]  

  • 14. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine in the treatment of depressed alcoholics.
    Mason BJ; Kocsis JH
    Am J Psychiatry; 1994 Aug; 151(8):1248. PubMed ID: 8037266
    [No Abstract]   [Full Text] [Related]  

  • 16. The challenges of control groups, placebos and blinding in clinical trials of dietary interventions.
    Staudacher HM; Irving PM; Lomer MCE; Whelan K
    Proc Nutr Soc; 2017 Aug; 76(3):203-212. PubMed ID: 28629483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebos used in clinical trials for Chinese herbal medicine.
    Qi GD; We DA; Chung LP; Fai CK
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):123-7. PubMed ID: 19076001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is your 'double-blind' design truly double-blind?
    Oxtoby A; Jones A; Robinson M
    Br J Psychiatry; 1989 Nov; 155():700-1. PubMed ID: 2611601
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstrating drug action.
    Tamminga CA
    Am J Psychiatry; 2004 Jun; 161(6):943-5. PubMed ID: 15169679
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind assessment of therapeutic efficacy in clinical trials.
    Cohen S
    Dig Dis Sci; 1983 Jun; 28(6):564-5. PubMed ID: 6861586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.